CDK12 and CDK13 suppress distinct intronic polyadenylation sites
Molly J. Hulver, Andrew Polevoda, Kai-Lieh Huang, Eric J. Wagner, Paul L. Boutz
This study shows CDK12 and CDK13 suppress distinct intronic polyadenylation sites, leading to premature termination and novel peptides in cancer.
bioRxiv · May 19, 2026 · PreprintGenomics